Intermittent fasting and metabolic dysfunction-associated steatotic liver disease: the potential role of the gut-liver axis
Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern linked to the increasing prevalence of metabolic syndrome, including obesity and type 2 diabetes (T2D). MASLD remains a significant clinical challenge due to the absence of effective therapeu...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Cell & Bioscience |
| Online Access: | https://doi.org/10.1186/s13578-025-01406-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|